BioTek Introduces New General Manager in Germany
News Nov 03, 2015
BioTek Instruments welcomes Dr. Frank Siefert as General Manager of BioTek Germany and the company’s European Coordination Center, which provides service applications and technical support throughout the continent. Dr. Siefert will be responsible for managing day-to-day operations in Germany and implementing local actions that align with the Company’s global business strategies and growth plans.
“Dr. Siefert brings the right blend of market and technology knowledge along with a drive for growth,” noted Peter Weith, BioTek’s Vice President of Marketing, Sales & Service. “We are confident that under his guiding leadership, we can continue our trend of significantly outpacing the market in this critical area, and especially with our Multi-mode Imaging Readers.”
Dr. Siefert’s expertise includes formerly serving as European Sales manager for BRAND GMBH + CO KG in Wertheim (Germany), and earlier as European Sales Manager for Detection for Tecan Deutschland GmbH in Crailsheim (Germany).
He completed his graduate studies at the BASF AG in Ludwigshafen and the Eberhard-Karls University in Tübingen (Germany), where he graduated Magna Cum Laude. He later accepted a Postdoctoral Fellowship at the BASF AG, prior to joining the commercial sector.
Compound Selectively Kills Liver Cancer Stem CellsNews
Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurrence of hepatocellular carcinoma (HCC), the most common form of liver cancer.READ MORE
170 Potential Lung Cancer Drug Targets Identified Using Unique Cellular LibraryNews
After testing more than 200,000 chemical compounds, UT Southwestern’s Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.READ MORE
Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug ScreeningNews
A multidisciplinary team of scientists share recent advancements in innovative in-vitro cancer biology methods for screening drug-like molecules in cancer tissue relevant models in a new report published online ahead-of-print at SLAS Discovery.READ MORE